Private Company Edition: The Paragon Biosciences-founded Emalex previously raised $35m when ecopipam was in Phase II. Also, Catalio Capital launches a “special situations” fund, Zenas raises $118m to develop a pipeline of autoimmune disease treatments and Lusaris emerges with $60m.

This month we profile Transcatheter Technologies, which is developing a repositionable TAVI implant, and Cutting Edge Spine, which has created a family of interbody spacers for spinal repair.

Cutting Edge Spine LLC has adopted a “less material” and “more open” engineering design philosophy to create its E-Vol family of interbody spacers. The start-up aims to offer implants that provide maximum bone/bone interface, loading and structural support and stability, to become a functional, integral part of the spine.

This Month's Profile Group, Hand Hygiene Surveillance Start-Ups, features profiles of BioVigil Systems, GLANTA, HanGenix and Proventix. Plus these Start-Ups Across Health Care: Cutting Edge Spine, Enterome, Molecular Dectecion and Transcatheter Technologies.